Calif. Federal Amiodarone Action Dismissed, Plaintiffs May Amend

SACRAMENTO, Calif. — An amiodarone death case in California federal court has been dismissed because, according to the judge, the plaintiffs did not adequately allege how the drug was defectively manufactured or how the FDA-approved warnings were inadequate.

In a Feb. 14 order, Senior Judge Anthony Ishii of the U.S. District Court for the Eastern District of California further found the plaintiffs failed to allege their fraud claims with the requisite specificity.

However, Judge Ishii allowed defendants to file an amended complaint, explaining that it cannot be determined at the present time whether amendment would be futile.

Agapita Marroquin …